Portfolio Update

RNS Number : 6901S

Intl. Biotechnology Trust PLC

14 September 2010

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

Portfolio Update as at 31 August 2010                                                                                   

Total net assets	£94.3m
NAV per share	156.3p
Share price	133.8p
Total value of unquoted investments	£24.1m
Total number of portfolio companies	58
Cash	2% NAV
Cash committed and reserved to unquoted investments	11% NAV
Portfolio companies with < 1 year of cash	8% NAV

Top Ten Holdings

Company Name	% NAV
Celgene	5.83
Genzyme	5.61
Amgen	5.48
Micromet	5.28
Shire Ltd	5.09
Alexion Pharmaceuticals	4.47
Gilead Sciences	4.26
Cadent	3.47
EUSA Pharma	3.23
Oxagen	2.90
	-----------
Total	45.62

Geographical Allocation	%
United States	75
Europe	20
Cash	2
Australia	2
Other	1
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	72
Unquoted	26
Cash	2
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

14 SEPTEMBER 2010

 

END

 

 

PFUBRGDCRGBBGGS